Johnson & Johnson vs. Eli Lilly & Co.
Johnson & Johnson (JNJ) comes out ahead, leading on 6 of 11 compared factors.
Size & Scale
| JNJ | LLY | |
|---|---|---|
| Market Cap | $650.65 billion | $1.03 trillion |
| Revenue (TTM) | $97.93 billion | $79.67 billion |
| Net Income (TTM) | $21.04 billion | $26.71 billion |
LLY leads on 2 of 3 size & scale factors.
Valuation
| JNJ | LLY | |
|---|---|---|
| P/E Ratio | 31.32 | 38.70 |
| Price / Book | 7.66 | 30.33 |
| Price / Sales | 6.64 | 12.90 |
JNJ leads on 3 of 3 valuation factors.
Profitability
| JNJ | LLY | |
|---|---|---|
| Net Margin | 21.48% | 33.53% |
| Return on Equity | 24.76% | 78.84% |
LLY leads on 2 of 2 profitability factors.
Dividend
| JNJ | LLY | |
|---|---|---|
| Dividend Yield | 1.99% | 0.60% |
| Payout Ratio | 62.18 | 23.23 |
JNJ and LLY split the dividend factors evenly.
Risk & Sentiment
| JNJ | LLY | |
|---|---|---|
| Short Interest | 0.67% | 1.29% |
JNJ leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, LLY overview, LLY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.